WallStreetZenWallStreetZen
Analyst Ranking
Top 7%
#274 out of 4484 analysts
Average Return
+17.06%
Win Rate
66%55 out of 83
Risk vs Reward
Poor
Good

Catherine Schulte's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Nanostring Technologies IncNSTGQ
+172.99%$25.14$68.63
2020-04-07 -
2021-04-07
Buy
Exact Sciences CorpEXAS
+117.49%$44.37$96.50
2018-02-27 -
2019-02-27
Buy
Castle Biosciences IncCSTL
+112.13%$28.27$59.97
2020-03-27 -
2021-03-26
Buy
Nanostring Technologies IncNSTGQ
+106.07%$14.00$28.85
2018-06-04 -
2019-06-04
Buy
Nanostring Technologies IncNSTGQ
+96.15%$7.79$15.28
2017-11-03 -
2018-11-02
Buy

Catherine Schulte Analyst Color

Get additional color on Catherine Schulte's coverage of popular stocks

Catherine Schulte's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Avantor IncAVTR
7Buy$26.00+4.00%Maintains
17 days ago
Thermo Fisher Scientific IncTMO
19Buy$670.00+16.25%Maintains
3 months ago
Agilent Technologies IncA
11Buy$130.00-6.52%Maintains
3 months ago
Qiagen NvQGEN
1Buy$51.50+18.53%Initiates Coverage On
6 months ago
Maravai Lifesciences Holdings IncMRVI
2Buy$11.00+44.93%Maintains
7 months ago
Exact Sciences CorpEXAS
10Buy$121.00+103.57%Maintains
7 months ago
Mettler Toledo International IncMTD
4Hold$1,366.00+7.73%Maintains
7 months ago
Revvity IncRVTY
5Buy$165.00+54.03%Maintains
10 months ago
Bio Techne CorpTECH
6Buy$100.00+34.44%Maintains
10 months ago
Danaher CorpDHR
3Buy$275.00+7.48%Maintains
10 months ago
Castle Biosciences IncCSTL
4Buy$38.00N/AMaintains
a year ago
Twist Bioscience CorpTWST
2Buy$33.00N/AMaintains
a year ago
Biora Therapeutics IncBIOR
1Hold$2.00N/ADowngrades
3 years ago
Chembio Diagnostics IncCEMI
1Buy$21.00N/AInitiates Coverage On
4 years ago
Illumina IncILMN
4Hold$310.00N/ADowngrades
4 years ago
Nanostring Technologies IncNSTGQ
5Buy$29.00N/AMaintains
4 years ago
Waters CorpWAT
5Hold$211.00N/ADowngrades
5 years ago
Natera IncNTRA
1Buy$20.00N/AMaintains
6 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.